FIELD: medicine.
SUBSTANCE: method is presented that involves serotonin concentration determination in serum, and at a value of 200 ng/ml and above, dystonic tremor is determined for cervical dystonia, below 200 ng/ml - tremor in Parkinson's disease is determined.
EFFECT: objectification and standardization of the diagnosis method.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PARKINSON'S DISEASE AND ESSENTIAL TREMOR | 2014 |
|
RU2558176C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF FUNCTIONAL HAND TREMOR AND HAND TREMOR IN ORGANIC PATHOLOGY OF NERVOUS SYSTEM | 2024 |
|
RU2824927C1 |
| USING HEPTAPEPTIDE FOR TREATING ESSENTIAL TREMOR AND METHOD OF TREATING TREMOR | 2011 |
|
RU2450821C1 |
| DIAGNOSTIC METHOD OF POSTURAL DISORDERS IN PARKINSON'S DISEASE | 2020 |
|
RU2733037C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF SYSTEMIC AND NON-SYSTEMIC DIZZINESS | 2022 |
|
RU2799621C1 |
| USE OF CARBAMATE COMPOUND FOR PREVENTION, RELIEF OR TREATMENT OF TREMORS OR TREMOR SYNDROME | 2017 |
|
RU2776368C2 |
| USING HEPTAPEPTIDE FOR TREATING PARKINSON'S DISEASE AND METHOD OF TREATING SUCH DISEASE | 2011 |
|
RU2450822C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR PARKINSONIAN DISEASE AND ESSENTIAL TREMOR | 2011 |
|
RU2467697C1 |
| METHOD OF SELECTING A THERAPEUTIC APPROACH TO PATIENTS WITH MUSCULAR DYSTONIA | 2018 |
|
RU2686083C1 |
| CARBAMATE DERIVATIVES FOR USING IN PROPHYLAXIS OR TREATMENT IN MOTION DISORDER | 2002 |
|
RU2294739C2 |
